Delcath: Fundamentals Intact, Despite Share Price Weakness [Seeking Alpha]
Delcath Systems, Inc. (DCTH)
US:NASDAQ Investor Relations:
delcath.com/investors
Company Research
Source: Seeking Alpha
The fundamentals of the company remain intact, though, and 2026 should be another year of strong growth. Delcath's profitability will be under pressure due to investments in clinical trials and sales and marketing. Even without success in CRC or breast cancer, Delcath's valuation appears low relative to its prospects. Rasi Bhadramani/iStock via Getty Images Delcath Systems, Inc. ( DCTH ) offers a liver-directed chemotherapy system, which is currently used to treat metastatic uveal melanoma patients. The business has been negatively impacted by pricing pressure and seasonality in recent quarters but is This article was written by Analyst's Disclosure: I/we have a beneficial long position in the shares of DCTH either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentio
Show less
Read more
Impact Snapshot
Event Time:
DCTH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DCTH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DCTH alerts
High impacting Delcath Systems, Inc. news events
Weekly update
A roundup of the hottest topics
DCTH
News
- Delcath Systems publishes results from CHOPIN trial in The Lancet Oncology [Yahoo! Finance]Yahoo! Finance
- Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology [Yahoo! Finance]Yahoo! Finance
- Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet OncologyBusiness Wire
- Delcath Systems Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Delcath Systems, Inc. (DCTH) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
DCTH
Earnings
- 2/26/26 - Beat
DCTH
Sec Filings
- 3/3/26 - Form 8-K
- 3/3/26 - Form 4
- 2/26/26 - Form 10-K
- DCTH's page on the SEC website